hiv aids

GSK's modern HIV drug to be rolled out in Botswana

The GlaxoSmithKline building in Hounslow, west London

The GlaxoSmithKline building in Hounslow, west London  (Copyright Reuters 2016)

An HIV drug first approved less than three years is to be rolled out in Botswana as a first-line core medicine to treat newly diagnosed patients under a contract agreed between the government and ViiV Healthcare.

More on this...

ViiV, which is majority-owned by GlaxoSmithKline, said on Friday it was the first time Tivicay, or dolutegravir, was being made available as part of a national health program in sub-Saharan Africa. No financial details were given.

Pfizer and Shionogi also hold minority stakes in ViiV.